<DOC>
	<DOC>NCT03018171</DOC>
	<brief_summary>Our study aims to evaluate the impact of the addition of 20 mcg of intrathecal clonidine in combined spinalepidural for labor analgesia on the local anesthetic consumption, on labor performance and on maternal fetal well-being.</brief_summary>
	<brief_title>Intrathecal Clonidine Addiction for Combined Spinal Epidural Analgesia During Labor</brief_title>
	<detailed_description />
	<mesh_term>Labor Pain</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<criteria>Written maternal informed consent Singleton pregnancy Gestational age ≥ 37 weeks, ASA I BMI &lt; 30 fetus in cephalic presentation Suspect or certainty of fetal malformation, Presence of conditions such as preeclampsia, multiparity, preterm labor History of adverse reaction to α2 adrenergic agonists Nicotine addiction Chronic use of opioid</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>clonidine, spinal injections</keyword>
</DOC>